Dolutegravir suits most people, which is why it is first-line almost everywhere. The reasons for not taking it are relatively few and mostly individual.
Who should avoid it outright?
Anyone with a documented hypersensitivity reaction to it. Anyone with significant integrase resistance, depending on the pattern, where higher dosing or a different class may be required.
What about liver impairment?
Not recommended in severe hepatic impairment, where it has not been adequately studied. Mild to moderate impairment does not require adjustment.
What about kidney impairment?
Dolutegravir itself is fine, since it is cleared by the liver. The constraint comes from whatever backbone accompanies it, and pairing it with something kidney-friendly is usually straightforward given how many combinations exist.
What about mood and sleep effects?
The commonest real-world reason people stop. If insomnia, anxiety or low mood appeared after starting and did not settle within a month or two, that is sufficient reason to switch and you do not need to justify it further.
Does a history of depression rule it out?
No, and it is worth mentioning before starting so that any change is noticed early. Many people with existing mental health difficulties take it without problems, and being alert to it is better than avoiding it pre-emptively.
What about pregnancy?
Recommended. An early signal from Botswana suggesting a possible increase in neural tube defects was not confirmed by larger data, and guidance was revised accordingly. Any individual decision is still made with a clinician.
What if you were switched away because of that signal?
Worth asking whether to switch back. A number of people were moved off dolutegravir during that period and were never reviewed afterwards, and the evidence has changed substantially since.
What about rifampicin?
Not a reason to avoid it. Dolutegravir is one of the few antiretrovirals that can be used alongside rifampicin, by doubling the dose to twice daily. That makes it useful where tuberculosis treatment is needed.
What about weight concerns?
Not a contraindication and a legitimate consideration. Someone who has gained significant weight on an integrase inhibitor may reasonably ask about alternatives with a different profile, particularly if the regimen also contains tenofovir alafenamide.
What about the specific combination?
Triumeq requires a negative genetic test because of its abacavir component. Dovato is not suitable where hepatitis B needs full cover or where the starting viral load is very high. These are constraints on the product rather than on dolutegravir.
What are the alternatives?
Bictegravir, very similar in class though available only in one combination. Raltegravir, older and extremely well tolerated with minimal interactions. Doravirine among the non-nucleosides. Boosted darunavir where a protease inhibitor is wanted.
What if integrase resistance is the issue?
Twice-daily dosing overcomes some resistance patterns. Where it does not, the options depend entirely on the specific mutations, and lenacapavir offers a mechanism no existing resistance affects.
Can you switch away easily?
Yes. Switching between regimens is routine and suppression is maintained provided the new one is fully active. A decision now is not permanent and does not narrow your options later.
Who decides?
You do, with a clinician. Suitability is a clinical judgement and the choice between suitable options is yours, including on grounds like sleep, mood and how a regimen fits your life.
Is a second opinion reasonable?
Entirely. If you have been told dolutegravir is your only option, or that you cannot change, asking to discuss it again or to see someone else is a normal part of care rather than a complaint about anyone.
Does avoiding it limit you later?
Rarely. Not taking it now does not rule it out in future and does not narrow the options available to you. Regimens are revisited regularly as circumstances and evidence change.
What should you bring to the conversation?
What is actually bothering you, in concrete terms, and what you would want instead if it were possible. That produces a more useful discussion than a general sense that something is not right.